Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3191735 | Annals of Allergy, Asthma & Immunology | 2013 | 6 Pages |
Abstract
These findings indicate that SIT normalizes the expression of CD86, HLA-DR, and TLR4 on DCs. Moreover, CD86, HLA-DR, and TLR4 may be useful parameters for monitoring SIT. Decreased TLR4 expression in allergic asthmatic patients might be compensated by TLR4 agonists, with the potential of amplifying the effects of SIT.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Chuang-Ming MD, MSc, Jing-Jing PhD,